Stock Fundamentals

Company Information

Company Name
Emergent Biosolutions Inc
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NYSE
ISIN: US29089Q1058
CIK: 0001367644
CUSIP: 29089Q105
Currency: USD
Full Time Employees: 900
Phone: 240 631 3200
Fiscal Year End: December
IPO Date: Nov 15, 2006
Description:

Emergent BioSolutions Inc., a life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States, Canada, and internationally. It operates through Commercial Products, MCM Products, and All Other Revenues segments. The company offers ACAM2000, a smallpox and mpox vaccine; Anthrax Immune Globulin Intravenous (ANTHRASIL), a polyclonal antibody therapeutic for the treatment of inhalational anthrax; Botulism Antitoxin Heptavalent (BAT), an equine plasma antitoxin for the treatment of symptomatic botulism; BioThrax, an anthrax vaccine; CYFENDUS, a vaccine for post-exposure prophylaxis of disease following suspected or confirmed exposure to Bacillus anthracis; Ebanga, a monoclonal antibody for the treatment of infection caused by Orthoebolavirus zairense; Raxibacumab injection, a monoclonal antibody therapeutic for the treatment and prophylaxis of inhalational anthrax due to Bacillus anthracis; TEMBEXA, an oral antiviral for the treatment of smallpox disease caused by variola virus in adult and pediatric patients; and CNJ-016, a polyclonal antibody therapeutic to address complications from smallpox vaccination. It also provides NARCAN and KLOXXADO nasal sprays for the emergency treatment of known or suspected opioid overdose. In addition, the company offers contract development and manufacturing services comprising drug substance and product manufacturing, and packaging, as well as technology transfer, process, analytical development, and suite reservation services. Emergent BioSolutions Inc. was incorporated in 1998 and is headquartered in Gaithersburg, Maryland.

Address:

300 Professional Drive, Gaithersburg, MD, United States, 20879

Directors & Officers

Name Title Year Born
Mr. Joseph C. Papa Jr., M.B.A., R.Ph. CEO, President & Director 1956
Mr. Richard S. Lindahl M.B.A. Executive VP & CFO 1964
Ms. Coleen Glessner Executive Vice President of Quality, Ethics & Compliance 1971
Mr. Paul A. Williams Senior Vice President of Products Business 1967
Mr. Simon C. Lowry M.D. Chief Medical Officer and Head of Research & Development 1973
Ms. Jessica Perl Senior VP, Corporate Secretary & General Counsel 1981
Ms. Michelle Pepin Senior VP & Chief Human Resource Officer NA
Ms. Stephanie Duatschek Chief Global Strategy & Franchise Development Officer NA
Mr. William Hartzel Senior Vice President of Manufacturing & Bioservices 1978
Mr. Frank Vargo VP & Treasurer NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Dec 05, 2025 Ronald Richard N/A Sale 21.98K $11.97 $263.15K
Oct 07, 2025 Coleen Glessner N/A Sale 30.61K $10.00 $306.08K
Aug 15, 2025 Kathryn C Zoon N/A Sale 7.09K $8.87 $62.85K
Aug 12, 2025 Donald W Degolyer N/A Sale 7.84K $8.65 $67.85K
May 23, 2025 Keith Katkin N/A Sale 7.84K $6.30 $49.42K

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
BlackRock Inc 4.34M Mar 31, 2026 8.41% $0.00 2.05%
Vanguard Group Inc 3.55M Dec 31, 2025 6.89% $0.00 0.38%
State Street Corp 2.85M Mar 31, 2026 5.52% $0.00 5.69%
Dimensional Fund Advisors, Inc. 2.76M Mar 31, 2026 5.34% $0.00 22.40%
American Century Companies Inc 2.43M Mar 31, 2026 4.70% $0.01 -0.56%
Vanguard Capital Management, LLC 2.26M Mar 31, 2026 4.38% $0.00 0.00%
Charles Schwab Investment Management Inc 1.51M Mar 31, 2026 2.92% $0.00 -6.97%
Acadian Asset Management LLC 1.38M Mar 31, 2026 2.68% $0.02 411.78%
Geode Capital Management, LLC 1.27M Mar 31, 2026 2.47% $0.00 1.83%
Palisade Capital Management LLc 1.20M Mar 31, 2026 2.33% $0.33 -5.09%
Vanguard Portfolio Management, LLC 1.12M Mar 31, 2026 2.17% $0.00 0.00%
Oak Hill Advisors LP 1.11M Mar 31, 2026 2.16% $1.05 -69.19%
D. E. Shaw & Co LP 1.00M Mar 31, 2026 1.95% $0.01 38.81%
AQR Capital Management LLC 989.68K Mar 31, 2026 1.92% $0.00 107.03%
LSV Asset Management 896.70K Mar 31, 2026 1.74% $0.02 -0.48%
The Goldman Sachs Group Inc 811.56K Mar 31, 2026 1.57% $0.00 9.66%
Prescott Group Capital Management LLC 772.77K Mar 31, 2026 1.50% $0.64 0.00%
Morgan Stanley - Brokerage Accounts 744.54K Mar 31, 2026 1.44% $0.00 -35.69%
Renaissance Technologies Corp 656.05K Mar 31, 2026 1.27% $0.01 13.67%
Connor Clark & Lunn Inv Mgmt Ltd 648.38K Mar 31, 2026 1.26% $0.01 -16.66%

Shares Statistics

Shares Outstanding: 51.60M
Shares Float: 49.39M
% Insiders: 384.80%
% Institutions: 8,573.70%
Short % Float: 19.22%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Avantis US Small Cap Value ETF 2.27M 4.40% ▲ 0.09% May 30, 2026
2 State Street® SPDR® S&P® Biotech ETF 1.75M 3.40% ▼ 0.62% May 31, 2026
3 Vanguard Total Stock Mkt Idx Inv 1.61M 3.12% ▲ 0.00% Apr 30, 2026
4 iShares Russell 2000 ETF 1.27M 2.46% ▲ 0.93% May 29, 2026
5 Palisade Small Cap Core Equity 872.78K 1.69% ▲ 1.37% Mar 31, 2026
6 Schwab Fundamental U.S. Small CompanyETF 757.64K 1.47% ▼ 0.04% May 30, 2026
7 Vanguard Institutional Extnd Mkt Idx Tr 596.80K 1.16% ▲ 0.53% Apr 30, 2026
8 DFA US Small Cap Value I 583.04K 1.13% ▲ 19.11% Apr 30, 2026
9 Fidelity Small Cap Index 511.09K 0.99% ▲ 0.09% Mar 31, 2026
10 Vanguard Strategic Equity Inv 465.32K 0.90% ▲ 0.00% Mar 31, 2026

Valuation Metrics

Enterprise Value: $842.58M
Trailing P/E: 0.00
Forward P/E: 2.08

Financial Highlights

Market Cap: $429.28M
EBITDA: $166.70M
PEG Ratio: $0.38
Book Value: $10.10
Earnings/Share: $-0.19
Profit Margin: -1.27%
Operating Margin: 6.79%
ROA (TTM): 3.43%
ROE (TTM): -1.60%
Revenue (TTM): $676.80M
Revenue/Share (TTM): $12.80
Earnings Growth (YOY): -93.80%
Revenue Growth (YOY): -29.70%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 5.01x 1.09x 0.60x 1.86x 2.38x
2024-12-31 3.69x 1.38x 0.65x -1.53x 12.48x
2023-12-31 1.04x 1.32x 0.64x -8.26x -18.30x
2022-12-31 0.98x 1.02x 0.56x -4.56x 89.91x
2021-12-31 3.40x 0.53x 0.46x 9.90x 1.68x
2020-12-31 3.11x 0.61x 0.50x 14.01x 1.45x
2019-12-31 3.17x 0.75x 0.53x 2.97x 3.15x
2018-12-31 3.10x 0.79x 0.55x 9.07x 5.12x
2017-12-31 4.85x 0.06x 0.15x 18.86x 0.32x
2016-12-31 4.82x 0.45x 0.39x 13.85x 2.02x
2015-12-31 5.41x 0.45x 0.37x 21.69x 1.59x
2014-12-31 4.65x 0.53x 0.41x 10.82x 2.39x
2013-12-31 4.82x 0.18x 0.22x N/A 1.35x
2012-12-31 4.25x 0.14x 0.22x 6,093.67x 1.31x
2011-12-31 3.58x 0.14x 0.24x N/A 1.44x
2010-12-31 3.22x 0.13x 0.25x N/A 0.60x
2009-12-31 3.54x 0.27x 0.29x 5,735.71x 1.41x
2008-12-31 2.83x 0.29x 0.31x 636.74x 1.54x
2007-12-31 2.59x 0.34x 0.37x 466.10x 1.53x
2006-12-31 2.29x 0.31x 0.42x 49.58x 0.97x
2005-12-31 1.96x 0.20x 0.40x N/A 0.47x
2004-12-31 1.22x 0.56x 0.67x N/A 0.69x
2003-12-31 N/A N/A N/A N/A 0.00x
2002-12-31 N/A 0.00x 0.82x N/A 0.00x
2001-12-31 3.11x -1.05x 2.27x -0.01x 0.75x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about EBS.US!